l 158809 has been researched along with Diabetic Glomerulosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adler, SG; Cheon Park, H; Ha, SK; Han, DS; Kang, SW; Natarajan, R; Ryu, DR; Xu, ZG; Yoo, TH | 1 |
1 other study(ies) available for l 158809 and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cell Cycle Proteins; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Cells; Glucose; Imidazoles; Kidney; Kidney Glomerulus; Male; Mice; Rats; Streptozocin; Tetrazoles; Tumor Suppressor Proteins | 2005 |